The physiology of pre-eclampsia

Area of Science:

• Obstetrics and Gynecology
• Maternal-Fetal Medicine
• Pathophysiology of Pregnancy Disorders

Background:

• Pre-eclampsia is a multisystem disorder of pregnancy with genetic links, commonly affecting first pregnancies.
• It impacts maternal renal, cerebral, hepatic, and clotting functions, leading to elevated blood pressure.
• Fetal effects arise from placental insufficiency due to abnormal trophoblast invasion and autacoid production.

Purpose of the Study:

• To review the current understanding of pre-eclampsia pathophysiology.
• To highlight the challenges in defining the balance of vasoactive factors.
• To emphasize the need for improved understanding for better clinical management.

Main Methods:

• Review of existing hypotheses on pre-eclampsia.
• Analysis of vasoactive factor imbalances (angiotensin II, prostacyclin, thromboxane, endothelin, nitric oxide, atrial natriuretic peptide).
• Examination of volume homeostasis disturbances and capillary permeability changes.

Main Results:

• Pre-eclampsia manifestations are secondary to organ hypoperfusion caused by vasoconstriction, coagulation, and reduced blood volume.
• Evidence suggests widespread maternal endothelial cell damage, possibly from placental factors.
• Abnormalities in vasoactive factors include enhanced angiotensin II pressor activity, reduced prostacyclin, and a pro-vasoconstriction thromboxane/prostacyclin balance.

Conclusions:

• The placenta causes pre-eclampsia, with delivery being the only cure.
• Disturbances in volume homeostasis involve fluid redistribution to the interstitial space.
• Further research into pre-eclampsia pathophysiology is essential for improved clinical management.